Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.5 CHF | 0.00% | +4.28% | -3.16% |
25/04 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
25/04 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
Sales 2023 * | 8.29M 9.06M 757M | Sales 2024 * | 51.09M 55.87M 4.66B | Capitalization | 87.54M 95.72M 7.99B |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | 10.6 x |
Net cash position 2023 * | - 0 0 | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | 1.71 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 46 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 70.73% |
Latest transcript on Santhera Pharmaceuticals Holding AG
1 week | +4.28% | ||
Current month | -2.76% | ||
1 month | -2.86% | ||
3 months | -1.66% | ||
6 months | -28.57% | ||
Current year | -3.16% |
Managers | Title | Age | Since |
---|---|---|---|
Dario Eklund
CEO | Chief Executive Officer | 56 | 01/19/01 |
Thomas Meier
FOU | Founder | 62 | 07/04/07 |
Andrew P. Smith
DFI | Director of Finance/CFO | 61 | 01/20/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Meier
FOU | Founder | 62 | 07/04/07 |
Director/Board Member | 56 | 04/17/04 | |
Otto Schwarz
BRD | Director/Board Member | 68 | 27/23/27 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 9.5 | 0.00% | 14,699 |
25/24/25 | 9.5 | +0.42% | 80,057 |
24/24/24 | 9.46 | -1.97% | 24,493 |
23/24/23 | 9.65 | +1.26% | 18,707 |
22/24/22 | 9.53 | +4.61% | 4,889 |
Delayed Quote Swiss Exchange, April 26, 2024 at 09:01 pm IST
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.16% | 95.7M | |
+5.31% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
+18.82% | 2.38B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B |
- Stock Market
- Equities
- SANN Stock